<DOC>
	<DOCNO>NCT00793130</DOCNO>
	<brief_summary>The aim study reduce severity duration acute attack , prevent recurrence new acute attack improve patient 's quality life . Coltect contain anti inflammatory antioxidant natural agent ( curcumin , green tea selenomethionine ) associate positive effect inflammatory disease . The investigator assume Coltect represent tolerable mild treatment , viable alternative medical therapy few side effect . Coltect food supplement contain active ingredient herbal source .</brief_summary>
	<brief_title>The Efficacy Tolerability Coltect Add-on Patients With Active Ulcerative Colitis - Open Label</brief_title>
	<detailed_description>Studies animal model colitis human IBD demonstrate component Coltect anti-inflammatory effect : Hanai H. et al demonstrate curcumin safe effective maintain remission patient quiescent UC . ( 7 ) B.Salh et al show curcumin , able attenuate colitis dinitrobenzene sulfonic acid ( DNB ) -induced murine model colitis . The immunohistochemical signal dramatically attenuate level mucosa curcumin . The author thus propose curcumin may therapeutic implication human IBD . ( 8 ) Potential Benefits Coltect- Coltect might suit treatment patient mild moderate flare-up ulcerative colitis . Coltect provide effect expect low incidence side effect . ( agent test find safe human use ) . The availability safe effective non-surgical non steroid treatment active ulcerative colitis . Overview - Clinical indication summary exist preclinical clinical knowledge pertain product . Coltect contain natural compound : curcumin , green tea selenium approve food supplement Ministry Health Israel . Curcumin green tea widely use food industry . Curcumin natural compound find plant Curcuma longa use food additive know turmeric . The major pigment turmeric curcumin - chemical name diferuloymethane , possess anti-inflammatory antioxidant property . Curcumin also strongly inhibit proliferation HT-29 HCT-15 human colon cancer cell line ( 1 ) . Dietary administration curcumin suppress development chemically induce cancer ( 1 ) . These property lead study chemopreventive effect curcumin also show agent reduces colonic inflammatory response . Curcumin profound immunosuppressive effect via inhibition IL-2 synthesis well IL-2 mitogen activation human leukocytes . This immunosuppressive effect may mediate NFκB inhibition ( 1 ) . Based aforementioned , curcumin appear reduce inflammatory response ulcerative colitis patient Clinical study curcumin show beneficial effect experimental study acute chronic disease characterize exaggerated inflammatory reaction . There ample evidence support clinical use prevention treatment set . Several natural substance curcumin great antioxidant effect conventional vitamin , include various polyphenols , flavonoid curcumenoids . Natural substance worth research experimentally clinically . Sting et al find : Curcumin show non-toxic , antioxidant activity , inhibit mediator inflammation NFkB , cyclooxygenase-2 ( COX-2 ) , lipooxygenase ( LOX ) , inducible nitric oxide synthase ( iNOS ) . ( 13 ) Ricky A. Sharma et al design dose-escalation study explore pharmacology curcumin human . Patients advanced colorectal cancer consume capsule compatible curcumin dose 0.45 3.6gr . daily 4 month . Curcumin well tolerate dose level , dose-limiting toxicity observe . At dose 3.6gr . mild diarrhea discernible toxicity . ( 2 ) Cheng et al . treated patient pre-malignant condition tablet contain pure curcumin 3 month daily dose high 8gr . without evident toxicity . They recommend common therapeutic dose would 400-600 mg curcumin 3 time daily . ( 14 ) Ricky el al show consumption 3.6 g curcumin daily cause inhibition PGE2 production blood leukocyte measure ex vivo . ( 2 ) In therapy UC , double blind placebo-controlled trial curcumin find clinical endoscopic evaluation score significantly improve curcumin therapy . The endoscopic score substantially improve compare placebo . The result study indicate turmeric component , curcumin , potentially promising medication treatment IBD ( 7 ) Green tea make unfermented , solely leave Camellia sinensis contain high concentration powerful antioxidant call polyphenols . The green tea polyphenols include ( - ) -epigallocatechin gallate ( EGCG ) , ( - ) epigallocatechin ( EGC ) , ( - ) -epicatechin gallate ( ECG ) ( - ) -epicatechin ( EC ) , potent antioxidant property . ( 9 ) Gary et al provide evidence green tea polyphenols anti-inflammatory effect murine colitis . They show mouse treat green tea polyphenols less severe colitis , green tea polyphenols widely distribute throughout body , one high tissue concentration find intestine . This distribution favor use gastrointestinal disease IBD . ( 9 ) Selenium essential trace element worldwide average nutritional intake 50 350 µg/d function antioxidant anti inflammatory associate colorectal cancer prevention . ( 10,11 ) Marwan et al establish safety administer high dose ( 2200 µg ) selenomethionine human cancer 13 month . ( 12 ) Toxicity high dose selenium appear mild headache , nausea heartburn .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>Age 1875 year old . Subjects mild moderate active ulcerative colitis Hemoglobin value great 10 g/dL . Aspartate aminotransferase alanine aminotransferase &lt; 1.5 time upper limit normal . Serum bilirubin creatinine &lt; 1.5 × upper limit normal . Subjects provide informed consent agree comply study procedure . Subjects Clinical Activity Index ( CAI ) &gt; 4 Subjects Clinical Activity Index ( CAI ) ≤8 Established new diagnosis . Subjects agree undergo sigmoidoscopy study completion Active chronic inflammatory autoimmune disease UC . Active infection , include viral infection . Active peptic ulcer disease . Infectious/ Ischemic colitis . Acute chronic cardiac , renal failure ( serum creatinine &gt; 300 mmol/L ) Abnormal liver function ( liver function test great 1.5 time upper range normal ) . Crohn 's disease . Use rectal corticosteroid within 4 week study entry . Patients know suspected bleeding tendency . Patients severe active ulcerative colitis . Present history colorectal cancer . Serious disease ( ) accord physician judgment preclude patient participation study . Toxic megacolon . Prior bowel resection . Baseline positive stool culture C DIFF toxin assay . Existing intended pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2008</verification_date>
	<keyword>Ulcerative</keyword>
	<keyword>Colitis</keyword>
	<keyword>Coltect</keyword>
	<keyword>Curcumin</keyword>
	<keyword>Green tea</keyword>
	<keyword>Selenium</keyword>
	<keyword>inflammation</keyword>
	<keyword>bowel</keyword>
</DOC>